Trial NCT04106843

View at ClinicalTrials.gov 
Org. Study IDs: 2018-0947
Secondary IDs: 2018-0947 NCI-2019-05859

Last trial update was posted on 2020-09-07

MeSH Interventions

Lutetium Lu 177 dotatate

MeSH Conditions

Carcinoma Carcinoma, Medullary Carcinoma, Neuroendocrine Paraganglioma Pheochromocytoma Pituitary Diseases Thyroid Diseases Thyroid Neoplasms

Other Conditions

Locally Advanced Adrenal Gland Pheochromocytoma Locally Advanced Paraganglioma Metastatic Adrenal Gland Pheochromocytoma Metastatic Paraganglioma Metastatic Parathyroid Gland Carcinoma Pituitary Gland Carcinoma Somatostatin Receptor Positive Stage III Thyroid Gland Medullary Carcinoma AJCC v8 Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8 Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8 Unresectable Adrenal Gland Pheochromocytoma Unresectable Paraganglioma

Stopping Reasons

No Participants Registered

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID